The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Clinical Roundup

Multicenter study reveals worse outcomes in understudied breast cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

A multicenter analysis of patients with invasive lobular carcinoma—the second most common histological subtype of invasive breast cancer in the U.S.—showed that, despite its prevalence, ILC is detected later and has worse outcomes than the predominant subtype of invasive breast cancer, known as invasive ductal carcinoma, or no special type.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

In Brief

NCCN tool enables care providers to earn credits while supporting cancer patients

The National Comprehensive Cancer Network has launched a continuing education resource called NCCN Guidelines in Practice. This subscription service equips health professionals with continuing education tools to support care decision-making and delivery according to the latest evidence-based, expert consensus-driven recommendations, while earning continuing education and Maintenance of Certification credits for the NCCN Guidelines engagement they are already doing during their daily clinical work.
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account